Lirimilast
CAS No. 329306-27-6
Lirimilast ( BAY 19-8004;BAY 198004 )
产品货号. M14085 CAS No. 329306-27-6
Lirimilast (BAY 19-8004;BAY 198004) is a potent and selective PDE4 inhibitor for the treatment of COPD.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥3767 | 有现货 |
|
50MG | ¥16038 | 有现货 |
|
100MG | ¥20250 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Lirimilast
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Lirimilast (BAY 19-8004;BAY 198004) is a potent and selective PDE4 inhibitor for the treatment of COPD.
-
产品描述Lirimilast (BAY 19-8004;BAY 198004) is a potent and selective PDE4 inhibitor for the treatment of COPD.COPD Phase 2 Discontinued
-
同义词BAY 19-8004;BAY 198004
-
通路Angiogenesis
-
靶点PDE
-
受体PDE
-
研究领域Inflammation/Immunology
-
适应症COPD
化学信息
-
CAS Number329306-27-6
-
分子量443.25
-
分子式C17H12Cl2N2O6S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCS(=O)(OC1=CC=C2C(NC(N)=O)=C(C(C3=CC=C(Cl)C=C3Cl)=O)OC2=C1)=O
-
化学全称[3-(carbamoylamino)-2-(2,4-dichlorobenzoyl)-1-benzofuran-6-yl] methanesulfonate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Grootendorst DC, et al. Pulm Pharmacol Ther. 2003;16(6):341-7.
产品手册
关联产品
-
CDP-840 hydrochlorid...
CDP-840 (CDP840;L-765527) is a potent and selective PDE4 inhibitor with IC50 of 4-45 nM.
-
Mirodenafil
Mirodenafil is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil (50 or 100 mg), obviously improved erectile function and was well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities.
-
Cilomilast
A potent and selective PDE4 inhibitor with IC50 of 95/120 nM for LPDE4/HPDE4.